Inhibition of energy metabolism by 2-methylacetoacetate and 2-methyl-3-hydroxybutyrate in cerebral cortex of developing rats

Journal of Inherited Metabolic Disease

Volumn 28, Issue 4, 2005, Pages 501-515

  Rosa, R B ^a   Schuck, P F ^a   De Assis, D R ^a   Latini, A ^a,b   Dalcin, K B ^a   Ribeiro, C A J ^a   Ferreira, G da C ^a   Maria, R C ^a   Leipnitz, G ^a   Perry, M L S ^a   Dutra Filho, C S ^a   Wyse, A T S ^a   Wannmacher, C M D ^a   Wajner, M ^a,b,c  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^c UNIVERSIDADE LUTERANA DO BRASIL   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

2 METHYL 3 HYDROXYBUTYRATE; 2 METHYL 3 HYDROXYBUTYRYL COENZYME A DEHYDROGENASE; 2 METHYL ACETOACETATE; 3 HYDROXYBUTYRIC ACID; ACETIC ACID; ACETOACETIC ACID DERIVATIVE; ACETYL COENZYME A ACYLTRANSFERASE; BUTYRYL COENZYME A DEHYDROGENASE; CARBON DIOXIDE; CITRIC ACID; CYTOCHROME C OXIDASE; GLUCOSE; GLUTATHIONE; GLYCYLGLYCINE; ISOLEUCINE; LACTIC ACID; MITOCHONDRIAL ENZYME; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; SUCCINATE DEHYDROGENASE; SUCCINATE DEHYDROGENASE (UBIQUINONE); UNCLASSIFIED DRUG;

AMINO ACID METABOLISM; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN DEVELOPMENT; CITRIC ACID CYCLE; COMA; CONTROLLED STUDY; CONVULSION; ENERGY METABOLISM; ENZYME DEFICIENCY; KETOACIDOSIS; LACTIC ACIDEMIA; LACTIC ACIDOSIS; MENTAL DEFICIENCY; METABOLIC ACIDOSIS; NONHUMAN; PARAMETER; PATHOPHYSIOLOGY; RAT; RESPIRATORY CHAIN; URINARY EXCRETION; VOMITING;

ACETATES; ACETOACETATES; ACETYL-COA C-ACYLTRANSFERASE; ACIDOSIS; ALCOHOL OXIDOREDUCTASES; ANIMALS; BRAIN; CARBON DIOXIDE; CEREBRAL CORTEX; CITRATES; CREATINE KINASE; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRON TRANSPORT; ENERGY METABOLISM; GLUCOSE; GLUTATHIONE; GLYCINE; HYDROXYBUTYRATES; LACTIC ACID; MENTAL RETARDATION; NG-NITROARGININE METHYL ESTER; OXYGEN; RATS; RATS, WISTAR; TIME FACTORS;

EID: 19944410542     PISSN: 01418955     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10545-005-0501-3     Document Type: Article

References (37)

1. Aksenov M, Aksenova M, Butterfield DA, Markesbery WR (2000) Oxidative modification of creatine kinase BB in Alzheimer's disease brain. J Neurochem 74: 2520-2527.
2. Aramaki S, Lehotay D, Sweetman L, Nyhan WL, Winter SC, Middleton B (1991) Urinary excretion of 2-methylacetoacetate, 2-methyl-3-hydroxybutyrate and tiglylglycine after isoleucine loading in the diagnosis of 2-methylacetoacetyl-CoA thiolase deficiency. J Inherit Metab Dis 14: 63-74.
3. Bennett MJ, Sherwood WG, Gibson K, Burlina AB (1993) Secondary inhibition of multiple NAD-requiring dehydrogenases in respiratory chain complex I deficiency: Possible metabolic markers for the primary defect. J Inherit Metab Dis 16: 560-562.
4. Burlina AB, Gibson KM, Ruitenbeek W, Bonafe L, Bennett MJ (1998) Profound neurological phenotype in a patient presenting with disordered isoleucine and energy metabolism. J Inherit Metab Dis 21: 864-866.
5. Capaldi RA, Halphen DG, Zhang YZ, YanamuraW(1988) Complexity and tissue specificity of the mitochondrial respiratory chain. J Bioenerg Biomembr 20: 291-311.
6. Cassina A, Radi R (1996) Differential inhibitory action of nitric oxide and peroxynitrite on mitochondrial electron transport. Arch Biochem Biophys 328: 309-316.
7. da Silva CG, Ribeiro CA, Leipnitz G, et al (2002) Inhibition of cytochrome c oxidase activity in rat cerebral cortex and human skeletal muscle by D-2-hydroxyglutaric acid in vitro. Biochim Biophys Acta 1586: 81-91.
8. Daum RS, Lamm PH, Mamer OA, Scriver CR (1971) A "new" disorder of isoleucine catabolism. Lancet 2: 1289-1290.
9. David S, Shoemaker M, Haley BE (1998) Abnormal properties of creatine kinase in Alzheimer's disease brain: Correlation of reduced enzyme activity and active site photolabeling with aberrant cytosol-membrane partitioning. Brain Res Mol Brain Res 54: 276-287.
10. Dutra-Filho CS, Wajner M, Gassen E, et al (1995) Effect of organic acids on in vitro glucose oxidation by cerebral cortex of young rats. Med Sci Res 23: 25-26.
11. Ebadi M, Sharma SK (2003) Peroxynitrite and mitochondrial dysfunction in the pathogenesis of Parkinson's disease. Antioxid Redox Signal 5: 319-335.
12. Ensenauer R, Neiderhoff H, Ruiter JPN, Wanders RJA (2002) Clinical variability in 3-hydroxy-2-methylbutyryl-CoA dehydrogenase deficiency. Ann Neurol 51: 656-659.
13. Fischer JC, Ruitenbeek W, Berden JA, et al (1985) Differential investigation of the capacity of succinate oxidation in human skeletal muscle. Clin Chim Acta 153: 23-36.
14. Gibson KM, Burlingame TG, Hogema B, et al (2000) 2-Methylbutyryl-coenzyme A dehydrogenase deficiency: A new inborn error of L-isoleucine metabolism. Pediatr Res 47: 830-833.
15. Hughes BP (1962) A method for the estimation of serum creatine kinase and its use in comparing creatine kinase and aldolase activity in normal and pathological sera. Clin Chim Acta 7: 597-603.
16. Hüttemann M, Schmidt TR, Grossman LI (2003) A third isoform of cytochrome c subunit VIII is present in mammals. Gene 312: 95-102.
17. Konorev EA, Hogg N, Kalyanaraman B (1998) Rapid and irreversible inhibition of creatine kinase by peroxynitrite. FEBS Lett 427: 171-174.
18. Kunz WS (2003) Different metabolic properties of mitochondrial oxidative phosphorylation in different cell types - important implications for mitochondrial cytopathies. Exp Physiol 88: 149-154.
19. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275.
20. Maker HS, Weiss C, Weissbarth S, Silides DJ, Whetsell W (1981) Regional activities of metabolic enzymes and glutamate decarboxylase in human brain. Ann Neurol 10: 377-383.
21. Mitchell GA, Fukao T (2001) Inborn errors of ketone body metabolism. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds; Childs B, Kinzler KW, Vogelstein B, assoc. eds. The Metabolic and Molecular Bases of Inherited Disease, 8th edn. New York: McGraw-Hill, 2328-2356.
22. Ofman R, Freenstra M, Ruiter JPN, Zschocke J, Wanders RJA (2001) 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase: Purification of the enzyme, cloning of the cDNA and resolution of the molecular basis of 2-methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency. J Inherit Metab Dis 24 (supplement 1): 60 [Abstract 120-O].
23. Oldendorf WH (1973) Carrier-mediated blood-brain barrier transport of short-chain monocarboxylic organic acids. Am J Physiol 224: 1450-1453.
24. Olpin SE, Pollitt RJ, McMenamin J, et al (2002) 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency in a 23-year-old man. J Inherit Metab Dis 25: 477-482.
25. Radi R, Cassina A, Hodara R (2002) Nitric oxide and peroxynitrite interactions with mitochondria. Biol Chem 383: 401-409.
26. Ramirez O, Jiménez E (2000) Opposite transitions of chick brain catalytically active cytosolic creatine kinase isoenzymes during development. Int J Dev Neurosci 18: 815-823.
27. Rustin P, Chretien D, Bourgeron T, et al (1994) Biochemical and molecular investigations in respiratory chain deficiencies. Clin Chim Acta 228: 35-51.
28. Saks VA, Kuznetsov AV, Kuprianov VV, Miceli MV, Jacobus WE (1985) Creatine kinase of rat heart mitochondria. The demonstration off unctional coupling to oxidative phosphorylation in an inner membrane-matrix preparation. J Biol Chem 260: 7757-7764.
29. Schapira AH, Cooper JM, Dexter D, Clark JB, Jenner P, Marsden CD (1990) Mitochondrial complex I deficiency in Parkinson's disease. J Neurochem 54: 823-827.
30. Søvik O (1993) Mitochondrial 2-methylacetoacetyl-CoA thiolase deficiency: An inborn error of isoleucine and ketone body metabolism. J Inherit Metab Dis 16: 46-54.
31. Stachowiak O, Dolder M, Wallimann T, Richter C (1998) Mitochondrial creatine kinase is a prime target of peroxynitrite-induced modification and inactivation. J Biol Chem 273: 16694-16699.
32. Sutton VR, O'Brien WE, Clark GD, Kim J, Wanders JA (2003) 3-Hydroxy-2-methylbutyryl-CoA dehydrogenase deficiency. J Inherit Metab Dis 26: 69-71.
33. Wallace DC (1999) Mitochondrial diseases in man and mouse. Science 283: 1482-1487.
34. Wallimann T, Doler M, Schlattner U, et al. (1998) Creatine kinase: An enzyme with central role in cellular energy metabolism. Magn Reson Mater Phys Biol Med 6: 116-119.
35. Wolosker H, Panizzutti R, Englender S (1996) Inhibition of creatine kinase by S-nitrosoglutathione. FEBS Lett 392: 274-276.
36. Wyss M, Kaddurah-Daouk R (2000) Creatine and creatinine metabolism. Physiol Rev 80: 1107-1213.
37. Zschocke J, Ruiter JPN, Brand J, et al (2000) Progressive infantile neurodegeneration caused by 2-methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency: A novel inborn error of branched-chain fatty acid and isoleucine metabolism. Pediatr Res 48: 852-855.